Aligos Therapeutics, Inc. (ALGS) Stock Profile — Insider Trades & Financials

Revenue$169.0K

Net Income-$19.9M

EPS$-2.45

Market Cap$48.7M

Price Performance

Historical data including institutional events

Loading price data...

Lawrence Blatt

CEO & Executive Director

Company profile for Aligos Therapeutics, Inc. (ALGS) stock, with a description, list of executives, contact details and other key facts.

Peer ComparisonRevenue ($B)

▾

⚡

ROE?

-37.13%

ROA?

-22.46%

D/E Ratio?

0.65

Op. Margin?

-12907.69%

📊

Net Margin?

-11763.91%

Loading company sections...